Compare INSG & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSG | BDSX |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Precision Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.1M | 154.8M |
| IPO Year | 2000 | 2020 |
| Metric | INSG | BDSX |
|---|---|---|
| Price | $10.52 | $15.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $15.33 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 448.1K | 33.7K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $313,832,000.00 | $88,499,000.00 |
| Revenue This Year | $16.21 | $25.26 |
| Revenue Next Year | $13.28 | $19.15 |
| P/E Ratio | $15.95 | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $6.28 | $0.26 |
| 52 Week High | $21.90 | $20.21 |
| Indicator | INSG | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 35.08 | 53.50 |
| Support Level | $9.35 | $13.46 |
| Resistance Level | $12.61 | $16.66 |
| Average True Range (ATR) | 1.23 | 0.96 |
| MACD | -0.29 | -0.10 |
| Stochastic Oscillator | 16.10 | 37.37 |
Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.